What's Hot

    M&G agrees two bulk purchase annuity deals totalling $760m

    21 September 2023

    ELSA Welcomes New Executive Board Members

    19 September 2023

    Editor’s Letter – Volume 2, Issue 9, September 2023

    15 September 2023
    Facebook Twitter Instagram
    Instagram LinkedIn Twitter
    Life Risk News
    • Home
    • Features

      Spotlight Falls on US Life Insurers’ Private Debt Investments

      14 September 2023

      The US Now The Last Remaining Traded Life Policy Market

      14 September 2023

      Re-Visiting the SEC Life Settlements Task Force More Than a Decade Later

      14 September 2023

      Generative AI Set to Transform Life Insurance Industry

      14 September 2023

      Q&A: David Blake, Professor of Finance & Director of Pensions Institute, Bayes Business School

      14 September 2023
    • Commentary

      The Critical Nature of Life Insurance Policy Due Diligence in the Life Settlement Asset Class

      14 September 2023

      Covid-19 Excess Mortality Analysis

      14 September 2023

      The Insurance Regulator Takes a Look at Funded Reinsurance

      10 August 2023

      Life Settlement Apocrypha

      10 August 2023

      UK Closed Life Funds – A Secret Returns Goldmine?

      12 July 2023
    • Events
    • Magazine
    • News

      M&G agrees two bulk purchase annuity deals totalling $760m

      21 September 2023

      ELSA Welcomes New Executive Board Members

      19 September 2023

      Prudential Financial and Warburg Pincus back new annuity reinsurer

      14 September 2023

      Ford UK pension scheme signs $450m partial buy-in deal

      14 September 2023

      European Life Settlement Association (ELSA) Hosts Successful Secondary Life Markets Conference 2023

      13 September 2023
    Subscribe
    Life Risk News
    Home»Magazine»Editor’s Letter – Volume 2, Issue 9, September 2023

    Editor’s Letter – Volume 2, Issue 9, September 2023

    Magazine 15 September 2023Chris WellsBy Chris Wells
    Twitter LinkedIn Email
    Editor's Letter
    Share
    Twitter LinkedIn Email

    Download Life Risk News Volume 2, Issue 9, September 2023

    The pension risk transfer market in the US is now a $50bn+ market, but unlike the UK, it’s one where private equity and private debt funds are playing increasing roles. That’s not gone unnoticed by some groups, so Aaron Woolner spoke to Charles Decker, a Researcher at UNITE HERE, and Joe Engelhard, Senior Counsel, US Policy & Regulation at the Alternative Investment Management Association to understand both the reservations that some have about this development, and the rebuttal, in Spotlight Falls on US Life Insurer’s Private Debt Investments, our cover story this month.

    Higher interest rates have had an impact on all alternative investment strategies in the past twelve months and will continue to do so as they remain elevated when compared to the post-GFC decade. Perhaps no impact, however, is greater than that of the German secondary life insurance policy market which, due to its structure, is now largely defunct. Greg Winterton spoke to Anna Bailey, a Board member at trade group BVZL, for her views on the likelihood of the market returning in The US Now The Last Remaining Traded Life Policy Market.

    The US Securities and Exchange Commission established a Life Settlement Task Force in 2009 to examine then-emerging issues in the life settlement market and advise whether market practices and regulatory oversight could be improved. Fourteen years later, the task force is yet to deliver its recommendations to Congress. Jeffrey Davis spoke to JoAnn M. Strasser, Partner and Chair, Investment Management at Thompson Hine LLP and Ron S. Geffner, Founding Partner at Sadis & Goldberg LLP, for their thoughts as to why in Re-Visiting the SEC Life Settlements Task Force More Than a Decade Later.

    Life insurance companies have a reputation for being something akin to an oil tanker – big, and slow. But their approach to incorporating generative AI (GenAI) into various functions of their businesses can hardly be claimed to be thus. A snap poll conducted by technology consulting firm, Celent, in July this year revealed that 10% of life insurers in the United States were already using GenAI in production. Greg Winterton spoke to Keith Raymond, Principal Analyst, Insurance at Celent to learn more about this trend in Generative AI Set to Transform Life Insurance Industry.

    Many investors in the life settlements asset class do not fully grasp the complexities underlying the asset before making the decision to invest in it; life settlements are more complicated to acquire and manage than other comparable discounted cash flow assets. Maurizio Pellegrini, Life ILS Manager at Azimut Investments, explains three areas that investors should pay close attention to before deploying capital in the space in The Critical Nature of Life Insurance Policy Due Diligence in the Life Settlement Asset Class, our first commentary article this month.

    The UK’s Continuous Mortality Investigation (CMI) carries out research into mortality and morbidity experience and produces practical tools that are widely used by actuaries. It published its most recent set of projections in July, showing lower life expectancies. So, for August’s poll, we asked, ‘How Significant Will the Impact of the Latest CMI Data on UK Life Expectancy Be on Life Risk Markets? ’

    The US Centers for Disease and Control (CDC) tracks all causes of death and has published provisional summary for 2022 deaths, including Covid-19 related deaths. However, the life insurance subset is generally a higher economic demographic subset with longer than average life expectancies, and John Lynch, Director of Actuarial & Underwriting Services, Longevity Holdings, takes a closer look at where Covid-19 and life settlements meet in Covid-19 Excess Mortality Analysis, our second commentary piece this month.

    The involvement of the capital markets in terms of its capability to absorb longevity risk has been talked about for years, but action has been largely absent. Greg Winterton caught up with David Blake, Professor of Finance & Director of the Pensions Institute, Bayes Business School, to get his thoughts on the current state of the longevity financing conundrum in this month’s Q&A.

    Participants in the UK equity release market – insurance companies, advisers and consultants – generally agree that the industry has something of an awareness challenge. But the current macroeconomic environment is changing that, and Greg Winterton spoke to Rudy Khaitan, Managing Partner at Senior Capital, Ben Grainger, Partner at EY, and Steve Kyle, Secretary General of European Pensions and Property Asset Release Group, to get their views on the outlook for growth in the market in Equity Release Fundamentals Underpin Growth Opportunity.

    I hope you enjoy the latest issue of Life Risk News.

    Chris Wells
    Managing Editor
    Life Risk News

     

     

    Editor's Letter Volume 2 Issue 9 - September 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Editor’s Letter – Volume 2, Issue 8, August 2023

    10 August 2023

    Editor’s Letter – Volume 2, Issue 7, July 2023

    12 July 2023

    Editor’s Letter – Volume 2, Issue 6, June 2023

    14 June 2023

    Editor’s Letter – Volume 2, Issue 5, May 2023

    12 May 2023

    Comments are closed.

    Most Popular

    Spotlight Falls on US Life Insurers’ Private Debt Investments

    14 September 2023

    The US Now The Last Remaining Traded Life Policy Market

    14 September 2023

    Re-Visiting the SEC Life Settlements Task Force More Than a Decade Later

    14 September 2023

    Generative AI Set to Transform Life Insurance Industry

    14 September 2023
    Ad

    Your trusted source for capital markets participation in Life Risk

    Twitter Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT